









Markets
/
Stocks
/
nasdaq-nnox
/

Nano-X Imaging Ltd

NNOX

3.150USD

-0.110-3.37%

Close 11/06, 16:00（ET）Quotes delayed by 15 min

201.03MMarket Cap

LossP/E TTM



Nano-X Imaging Ltd

3.150

-0.110-3.37%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Nano-X Imaging Ltd

Currency: USD Updated: 2025-11-06

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a very weak stock market performance, the company shows strong technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Nano-X Imaging Ltd's Score

Industry at a Glance

Industry Ranking

108 / 210

Overall Ranking

260 / 4615

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 4 analysts

Buy

Current Rating

7.750

Target Price

+137.73%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Nano-X Imaging Ltd Highlights

StrengthsRisks

Nano-X Imaging Ltd is an Israel-based company that develops a digital X-ray source enabling a cost reduction of imaging systems.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 31.53% year-on-year.

Growing

The company is in a growing phase, with the latest annual income totaling USD 11.28M.

Overvalued

The company’s latest PE is -3.48, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 13.42M shares, decreasing 34.91% quarter-over-quarter.

Held by PRFDX

Star Investor PRFDX holds 4.54K shares of this stock.

Financial Health

Currency: USD Updated: 2025-11-06

The company's current financial score is 5.33, which is lower than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is weak, and its operating efficiency is low. Its latest quarterly revenue reached 3.04M, representing a year-over-year increase of 12.63%, while its net profit experienced a year-over-year increase of 8.45%.

Score

Industry at a Glance

Previous score

5.33

Change



Financials

5.99

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

6.52

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

2.57

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

4.44

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.10

Key Metrics

Free cash flow

No Data

Nano-X Imaging Ltd's Company Valuation

Currency: USD Updated: 2025-11-06

The company’s current valuation score is 7.53, which is higher than the Healthcare Equipment & Supplies industry's average of 7.19. Its current P/E ratio is -3.48, which is -25.45% below the recent high of -2.60 and -244.85% above the recent low of -12.01.

Score

Industry at a Glance

Previous score

7.53

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 108/210

No Data

Earnings Forecast

Currency: USD Updated: 2025-11-06

The company’s current earnings forecast score is 8.50, which is higher than the Healthcare Equipment & Supplies industry's average of 7.74. The average price target for Nano-X Imaging Ltd is 7.50, with a high of 10.00 and a low of 6.00.

Score

Industry at a Glance

Previous score

8.50

Change

Support & Resistance

No Data

Analyst Rating

Based on 4 analysts

Buy

Current Rating

7.750

Target Price

+137.73%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Nano-X Imaging Ltd

NNOX

Boston Scientific Corp

BSX

Intuitive Surgical Inc

ISRG

Edwards Lifesciences Corp

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-06

The company’s current price momentum score is 6.25, which is lower than the Healthcare Equipment & Supplies industry's average of 6.74. Sideways: Currently, the stock price is trading between the resistance level at 4.05 and the support level at 2.69, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.22

Change

0.03

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(4)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.189

Sell

RSI(14)

29.348

Sell

STOCH(KDJ)(9,3,3)

3.107

Oversold

ATR(14)

0.191

Low Volatility

CCI(14)

-132.285

Sell

Williams %R

97.899

Oversold

TRIX(12,20)

-0.520

Sell

StochRSI(14)

0.000

Oversold

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

3.340

Sell

MA10

3.606

Sell

MA20

3.851

Sell

MA50

3.882

Sell

MA100

4.361

Sell

MA200

5.046

Sell

Institutional Confidence

Currency: USD Updated: 2025-11-06

The company’s current institutional recognition score is 3.00, which is lower than the Healthcare Equipment & Supplies industry's average of 6.40. The latest institutional shareholding proportion is 20.98%, representing a quarter-over-quarter decrease of 15.32%. The largest institutional shareholder is The Vanguard, holding a total of 412.84K shares, representing 0.65% of shares outstanding, with 1.70% increase in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

BlackRock Institutional Trust Company, N.A.

3.18M

+10.85%

State Street Investment Management (US)

1.17M

+5.52%

Geode Capital Management, L.L.C.

810.32K

+17.46%

UBS Asset Management Switzerland AG

650.00K

UBS Switzerland AG

505.50K

-57.46%

National Bank of Canada

477.33K

+35.06%

The Vanguard Group, Inc.

Star Investors

412.84K

+13.10%

Morgan Stanley Smith Barney LLC

369.38K

-6.93%

Northern Trust Investments, Inc.

348.58K

+2.81%

Morgan Stanley & Co. LLC

326.26K

+16.73%

Risk Assessment

Currency: USD Updated: 2025-11-06

The company’s current risk assessment score is 4.88, which is higher than the Healthcare Equipment & Supplies industry's average of 4.57. The company's beta value is 1.10. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.